Page last updated: 2024-09-02

cobaltiprotoporphyrin and Diabetic Glomerulosclerosis

cobaltiprotoporphyrin has been researched along with Diabetic Glomerulosclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abo El Gheit, R; Emam, MN1
Baban, B; Elmarakby, AA; Faulkner, J; Saleh, MA; Sullivan, JC1

Other Studies

2 other study(ies) available for cobaltiprotoporphyrin and Diabetic Glomerulosclerosis

ArticleYear
Targeting heme oxygenase-1 in early diabetic nephropathy in streptozotocin-induced diabetic rats.
    Physiology international, 2016, Volume: 103, Issue:4

    Topics: Animals; Biomarkers; Blood Glucose; Chemokine CCL2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Induction; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Hydroxyproline; Insulin; Intercellular Adhesion Molecule-1; Kidney; Male; Molecular Targeted Therapy; NADPH Oxidases; NF-kappa B; Protoporphyrins; Rats; Streptozocin; Tumor Necrosis Factor-alpha

2016
Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats.
    American journal of physiology. Renal physiology, 2012, Apr-01, Volume: 302, Issue:7

    Topics: Animals; Apoptosis; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; Heme Oxygenase-1; Hypertension; Inflammation; Kidney Glomerulus; Male; Nephrosclerosis; Oxidative Stress; Permeability; Proteinuria; Protoporphyrins; Random Allocation; Rats; Rats, Inbred SHR

2012